83894 Federal Register / Vol. 89, No. 202 / Friday, October 18, 2024 / Notices 

guidance-documents, or https://

www.regulations.gov. 

Dated: October 10, 2024. 

Eric Flamm, 

Acting Associate Commissioner for Policy. 

[FR Doc. 2024–24108 Filed 10–17–24; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Meeting of the National Advisory 

Council on Migrant Health; Amended 

Notice of Meeting 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Notice; amended notice of 

meeting. 

SUMMARY: HRSA published a notice in 

the Federal Register of July 23, 2024, 

concerning a meeting of the National 

Advisory Council on Migrant Health on 

October 22, 2024, and October 23, 2024. 

The notice states the meeting will be 

held in-person and via webinar. 

However, due to the impact of recent 

hurricanes on council members, this 

meeting now will be held via webinar 

only on Zoom. 

FOR FURTHER INFORMATION CONTACT: Liz 

Rhee, National Advisory Council on 

Migrant Health Designated Federal 

Official, Office of Policy and Program 

Development, Bureau of Primary Health 

Care, HRSA, 5600 Fishers Lane, 

Rockville, MD 20857; 301–443–1082 or 

hrsabphcoppdnacmh@hrsa.gov. 

SUPPLEMENTARY INFORMATION: 

Amended Notice of Meeting 

In the Federal Register Notice of July 

23, 2024, FR Doc. 2024–16119, page 

59744, column 1, section 2, paragraph 3, 

amend the sentences ‘‘This meeting will 

be held in-person and via webinar. The 

address of the meeting is 5600 Fishers 

Lane, Rockville, MD 20857’’ to read: 

‘‘This meeting will be held via webinar 

only.’’ In paragraph 8, delete the 

following sentences: ‘‘Since this 

meeting occurs in a federal government 

building, attendees must go through a 

security check to enter the building. 

Non-U.S. citizen attendees must notify 

HRSA of their planned attendance at 

least 20 business days prior to the 

meeting to facilitate their entry into the 

building. All attendees are required to 

present government-issued 

identification prior to entry.’’ 

Amy P. McNulty, 

Deputy Director, Executive Secretariat. 

[FR Doc. 2024–24165 Filed 10–17–24; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Charter Renewal of the Advisory 

Committee on Blood and Tissue Safety 

and Availability 

AGENCY: Office of the Assistant 

Secretary for Health, Office of the 

Secretary, Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: The Department of Health and 

Human Services is hereby giving notice 

that the charter for the Advisory 

Committee on Blood and Tissue Safety 

and Availability (ACBTSA) has been 

renewed. 

FOR FURTHER INFORMATION CONTACT: 

James Berger, Designated Federal Officer 

for the ACBTSA; Office of Infectious 

Disease and HIV/AIDS Policy, Office of 

the Assistant Secretary for Health, 

Department of Health and Human 

Services, Tower Building, 1101 Wootton 

Parkway, Rockville, MD 20852. Phone: 

(202) 795–7608. Email: ACBTSA@

hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

ACBTSA is a non-discretionary federal 

advisory committee. The ACBTSA is 

authorized under 42 U.S.C. 217a, 

section 222 of the Public Health Service 

(PHS) Act, as amended. The Committee 

is governed by the provisions of the 

Federal Advisory Committee Act 

(FACA), Public Law 92–463, as 

amended (5 U.S.C. App), which sets 

forth standards for the formation and 

use of advisory committees. The 

ACBTSA advises, assists, consults with, 

and makes policy recommendations to 

the Secretary, through the Assistant 

Secretary for Health, regarding broad 

responsibilities related to the safety of 

blood, blood products, tissues, and 

organs. For solid organs and blood stem 

cells, the Committee’s work is limited to 

policy issues related to donor derived 

infectious disease complications of 

transplantation. 

To carry out its mission, the ACBTSA 

provides advice to the Secretary through 

the Assistant Secretary for Health on a 

range of policy issues which includes: 

(1) identification of public health issues 

through surveillance of blood and tissue 

safety issues with national biovigilance 

data tools; (2) identification of public 

health issues that affect availability of 

blood, blood products, and tissues; (3) 

broad public health, ethical, and legal 

issues related to the safety of blood, 

blood products, and tissues; (4) the 

impact of various economic factors (e.g., 

product cost and supply) on safety and 

availability of blood, blood products, 

and tissues; (5) risk communications 

related to blood transfusion and tissue 

transplantation; and (6) identification of 

infectious disease transmission issues 

for blood, organs, blood stem cells and 

tissues. 

On September 25, 2024, the Secretary 

approved for the ACBTSA charter to be 

renewed. Renewal of the Committee’s 

charter gives authorization for the 

Committee to continue to operate until 

October 9, 2026. 

A copy of the ACBTSA charter is 

available on the Committee’s website at 

https://www.hhs.gov/oidp/advisorycommittee/blood-tissue-safetyavailability/charter/index.html. 

Dated: October 3, 2024. 

James J. Berger, 

DFO, Advisory Committee on Blood and 

Tissue Safety and Availability, Office of 

Infectious Disease and HIV/AIDS Policy. 

[FR Doc. 2024–24133 Filed 10–17–24; 8:45 am] 

BILLING CODE 4150–41–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the Secretary’s Advisory 

Committee on Human Research 

Protections 

AGENCY: Department of Health and 

Human Services, Office of the Secretary, 

Office of the Assistant Secretary for 

Health. 

ACTION: Notice. 

SUMMARY: Pursuant to section 10(a) of 

the Federal Advisory Committee Act, 

U.S.C. Appendix 2, notice is hereby 

given that the Secretary’s Advisory 

Committee on Human Research 

Protections (SACHRP) will hold a 

meeting that will be open to the public. 

Information about SACHRP, the full 

meeting agenda, and instructions for 

linking to public access will be posted 

on the SACHRP website at https://

www.hhs.gov/ohrp/sachrp-committee/ 

meetings/index.html. 

DATES: The meeting will be held on 

Tuesday, October 22, 2024, from 11:00 

a.m. until 4:30 p.m. (times are tentative 

and subject to change). The confirmed 

times and agenda will be posted on the 

SACHRP website as this information 

becomes available. 

ADDRESSES: This meeting will be held 

via webcast. Members of the public may 


khammond on DSKJM1Z7X2PROD with NOTICES